We are pleased to make available a couple of presentations that were first held during the EHA2022 Congress in Vienna. Presentations include; 'Non-BCR-ABL1 molecular biomarkers of prognosis in CML' and 'Mechanisms of disease progression in chronic myeloid leukemia'. |
![]() |
Non-BCR-ABL1 molecular biomarkers of prognosis in CML
|
This talk was first presented during the Scientific Working Group Session – ELN-EHA-SWG for CML: 'Understanding the pathogenesis of CML' at EHA 2022
![]() |
Mechanisms of disease progression in chronic myeloid leukemia Learning goals:
|
This talk was first presented during the Scientific Working Group Session – ELN-EHA-SWG for CML: 'Understanding the pathogenesis of CML' at EHA 2022
Presentations from the COLT Meeting 2019We are pleased to make available a series of presentations from the COLT Meeting 2019, a CML Opinion Leader Training that took place in Adelaide (Australia). Topics cover; CML therapy - state of science, management of CML, practicalities and monitoring TFR and Ph+ALL. |
|||
|
![]() |
![]() |
Session 1: CML therapy - state of science
|
|
![]() |
![]() |
Session 2: CML Management, Practicalities
|
|
![]() |
Session 3: Monitoring TFR and Ph+ ALL
|